Vaccentis attends the Sachs conference and Bio Europe Spring in Basel to present the core business strategy for the oncological tumor vaccine VCC-001 and pipeline platform.
Vaccentis attends the Sachs conference and Bio Europe Spring in Basel to present the core business strategy for the oncological tumor vaccine VCC-001 and pipeline platform.